Toledo, OH, United States of America

Steven Charles Reitz



Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 93(Granted Patents)


Location History:

  • Holland, OH (US) (2005)
  • Toledo, OH (US) (2006)

Company Filing History:


Years Active: 2005-2006

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Steven Charles Reitz: Innovator in Pharmaceutical Compounds

Introduction

Steven Charles Reitz is a notable inventor based in Toledo, OH (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 3 patents, focusing on innovative compounds that have potential therapeutic applications.

Latest Patents

Reitz's latest patents include "Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease." This invention provides compounds of Formula I, where W is defined, and these compounds may exist as pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers. They are particularly useful in treating diseases or conditions associated with the α7 nicotinic acetylcholine receptor. Another significant patent is "Azabicyclic compounds for the treatment of disease," which details compounds of Formula I, wherein Azabicyclo is a six-membered heterocyclic ring system with nitrogen atoms. These compounds may also be in the form of pharmaceutical salts or compositions and are beneficial in treating diseases linked to the α7 receptor.

Career Highlights

Throughout his career, Steven Reitz has worked with prominent companies such as Pfizer Corporation and Pharmacia & Upjohn Company. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Reitz has collaborated with notable coworkers, including David W. Piotrowski and Donn G. Wishka, enhancing his work through shared knowledge and expertise.

Conclusion

Steven Charles Reitz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…